Based on our above studies in network pharmacology and molecular docking, we screened and predicted that Kaempferol treatment exhibits a high binding affinity for IL6, CASP3, and MMP9, suggesting that these proteins may be the primary targets of Kaempferol in the treatment of periodontitis. This evidence concerns the gene CASP3 and periodontitis.